INTRODUCTION
Epidermal growth factor (EGF) and transforming growth factorac (TGF-a) are structurally related polypeptide growth factors (Massague, 1983) . EGF and TGF-a exhibit very similar affinity constants for the EGF receptor (Massague, 1983; Ebner and Derynck, 1991) and, in general, exert similar biological effects. TGF-a, however, appears to be more potent than EGF in some assays (Myrdal et al., 1986; Schreiber et al., 1986; Barrandon and Green, 1987) , which may be due to differences in processing of EGF-receptor and TGF-a-receptor complexes (Ebner and Derynck, 1991) .
There are now a number of lines of evidence to suggest that TGF-a plays an important role in autocrine and paracrine growth regulation in human skin. EGF and TGF-a are mitogenic for human keratinocytes and dermal fibroblasts (Harper and Savage, 1980; Barrandon and Green, 1987; Pittelkow et al., 1989) . TGF-a mRNA and protein are synthesized in cultured human keratinocytes (Coffey et al., 1987; Cook et al., 1991) and in normal epidermis (Coffey et al., 1987; Elder et al., 1989) , and are markedly over-expressed in hyperproliferative psoriatic epidermis (Gottlieb et al., 1988; Elder et al., 1989) . Furthermore, epidermal hyperplasia and increased papilloma formation were kinase substrate, 'MARCKS'). In keratinocytes, TGF-a and EGF induced only a modest increase in MARCKS protein phosphorylation. This apparent modest activation of PKC, in the absence of detectable DAG formation, may have been mediated by arachidonic acid, which was released from keratinocytes in response to TGF-a, and has been shown to stimulate PKC activity in vitro. These data demonstrate that (1) in dermal fibroblasts and keratinocytes, which express normal levels of EGF receptors, EGF receptor activation is not coupled to tyrosine phosphorylation of PLC-yl or Ptdlns hydrolysis, suggesting that these events are not required for the mitogenic activity of EGF or TGF-a in these cells, (2) coupling of EGF receptor to PC hydrolysis is cell-type specific, and (3) in skin fibroblasts, DAG, formed through EGF-induced PC hydrolysis, is capable of activating PKC.
observed after over-expression of TGF-a in the epidermis of transgenic mice (Vassar and Fuchs, 1991) .
The EGF receptor possesses ligand-dependent tyrosine kinase activity that is required for the biological effects of EGF and TGF-a, including cell growth (Chen et al., 1987) . The binding of EGF or TGF-a to the EGF receptor results in dimerization of the receptor and activation ofits intrinsic tyrosine kinase activity, leading to autophosphorylation (reviewed in Carpenter and Cohen, 1990) . Autophosphorylation of the EGF receptor promotes binding and phosphorylation of phospholipase C-yl (PLC-yl) (Vega et al., 1992) . This results in stimulation of PLCyl activity, which requires both tyrosine phosphorylation and binding to the EGF receptor (Vega et al., 1992) . Activated PLCyl hydrolyses PtdIns(4,5)P2 to yield at least three important second messengers including Ins(1,4,5)P3 and Ins(l,3,4,5)P4, 536 N. J. Reynolds and others cells that express normal numbers of EGF receptors. EGFinduced mitogenesis in the absence of detectable inositol phospholipid hydrolysis has been reported in Balb/c/3T3 fibroblasts (Besterman et al., 1986) , and Chinese hamster embryo fibroblasts (IIC9 cells), (Wright et al., 1988) . On the other hand, stimulation of Ptdlns hydrolysis by EGF has been reported in Balb/MK cells (Moscat et al., 1988) , pig thyroid cells (Takasu et al., 1988) and rat hepatocytes (Tsao et al., 1986; Johnson and Garrison, 1987; Hepler et al., 1988) . The reason for this difference among different cell types has not been fully explained, although differences in cell clones, experimental conditions, including the presence or absence of serum, and cell state may play some role (reviewed by Whitman and Cantley, 1989) .
Agonist-stimulated accumulation of 1,2-DAG may occur through pathways other than PLC-induced PtdIns(4,5)P2
hydrolysis. Phosphatidylcholine (PC) and phosphatidylethanolamine may also be hydrolysed, by distinct PLCs, to yield 1,2-DAG directly (reviewed by Exton, 1990; Dennis et al., 1991) . Alternatively 1,2-DAG may be generated by the sequential action of phospholipase D (PLD) and phosphatidate phosphohydrolase (Bocckino et al., 1987; van Blitterswijk et al., 1991) . Indeed, PC hydrolysis through PLC and/or PLD activity may be the major source of agonist-induced 1,2-DAG formation in certain cell types. Moreover, recent evidence suggests that PC hydrolysis may be important in the control of cell growth (Wright et al., 1988; Larrodera et al., 1990) . Synthesis de novo may also contribute to elevated 1,2-DAG in agonist-treated cells (Farese et al., 1987) . We and others have previously reported EGF-stimulated DAG accumulation through hydrolysis of PC (Wright et al., 1988; Pessin et al., 1990; Fisher et al., 1991) , but it remains unclear whether DAG derived from PC can activate PKC. In the present study, we have extended our previous observations in human dermal fibroblasts, to address this issue directly. In addition, we have examined the relationship between EGF receptor activation and the PLC/PKC signal-transduction system in human keratinocytes, a second major cell type in skin, for which EGF and TGF-a are mitogenic. (Lobaugh and Blackshear, 1990) was generously given by Dr. P. J. Blackshear. Bryostatin was generously given by Dr. G. R. Petitt. All other chemicals were of at least reagent grade.
EXPERIMENTAL
Cell culture Dermal fibroblasts and keratinocytes were cultured from keratome biopsies of adult human skin as previously described (Talwar et al., 1989; Fisher et al., 1991 (Downes et al., 1982) .
Ins(1,4,5)P3 levels were determined by a binding assay as described by Fu et al. (1988) .
1251-EGF binding
This was carried out essentially as previously described (Nickoloff and Mitra, 1989) . Non-specific binding was determined as cellassociated radioactivity in the presence of 500-fold excess of unlabelled EGF as previously described (Zachary et al., 1986) . Parallel dishes of cells were trypsin-treated, and cell numbers determined with a haemocytometer. The dissociation constant (Kd) and receptor number were estimated by Scatchard (1949) analysis.
Immunoprecipitation of PLC-yl Cells were scraped into a buffer as described by Decker et al. (1990) . Half of the lysate was preabsorbed with Pansorbin and then immunoprecipitated with anti-PLC-yl rabbit polyclonal antiserum (10 ,ul/ml of lysate) or mixed monoclonal antibodies (1.0,ul/ml of lysate) as described previously (Decker et al., 1990; Meisenhelder et al., 1989) .
Protein kinase C activation by growth factors in human skin cells
Immunoblot analysis
Paired cell lysates and PLC-yl immunoprecipitates were separated on 8 %-polyacrylamide gels and proteins were transferred to nitrocellulose membranes. Blots were blocked in Ca2+/Mg2+-free PBS containing 0.05 % Tween 20 and 5 % powdered milk and then incubated with either anti-phosphotyrosine monoclonal antibody diluted 1:1000 or anti-PLC-yI mixed monoclonal antibodies diluted 1: 500. After washing, proteins were detected by using the enhanced chemiluminescence Western-blotting detection system (Amersham).
Measurement of choline and phosphochollne
[3H]Choline-labelled cells were incubated with the specified agonists, and the reactions were terminated as described by Fisher et al. (1991) . Dried samples of the aspirated medium and aqueous cellular layer were redissolved in 50 % methanol and analysed by t.l.c. using the solvent methanol/0.5 % NaCl/30 % NH3 in water (50: 50: 1, by vol.) as described by Yavin (1976) .
Analysis of [3H]myristic acid metabolites
To measure the conversion of PC into phosphatidylethanol, [3H]myristic acid-labelled keratinocytes were washed with Ca2+/Mg2+-free PBS to remove unincorporated label and placed, at timed intervals, in fresh basal medium containing 0.5 % ethanol for 15 min. Cells were treated with agonists as specified in the text, scraped into 1 ml of ice-cold methanol, and cellular lipids were extracted with chloroform (Preiss et al., 1987) .
[3H]Phosphatidylethanol and neutral lipids were analysed by t.l.c. as described by Billah et al. (1989) .
Measurement in vitro of membrane-associated and cytosolic PLD activity After preparation of soluble and particulate fraction, membraneassociated and soluble PLD activities were determined as described by Martin (1988) and Wang et al. (1991) respectively. 14C-labelled products were separated by t.l.c. (Wang et al., 1991) , detected and quantified by using a Phosphorlmager (Molecular Dynamics).
Measurement in vitro of PC-specific PLC activity
Cultures of fibroblasts and keratinocytes, in 100 mm dishes, were washed twice in ice-cold Ca2+/Mg2+-free PBS, scraped into buffer A, homogenized, and centrifuged at 100000g for 1 h at 4 'C. The pellet was resuspended in buffer A by 10 passages through a 23-gauge needle. Samples of the supernatant and resuspended pellet were assayed for PC-specific PLC activity as described by Wolf and Gross (1985) . T.l 
Measurement of MARCKS protein phosphorylation
[32P]P1 was added to cell cultures for 3 h at timed intervals to ensure equal labelling times and minimize variation in specific radioactivity of cellular ATP. Cells were then incubated with agonists as specified in the text. MARCKS protein was immunoprecipitated as described by Lobaugh and Blackshear (1990) . Alternatively, MARCKS protein phosphorylation was assessed in cell lysates as described by Issandou and Rozengurt (1990) . Autoradiograms of dried gels were scanned with a laser densitometer. Dried gels were also analysed by using a PhosphorImager; the incorporation of [32P]P1 into MARCKS was quantified and normalized to the total radioactivity in the lane (to allow for variation in labelling and loading). Results were expressed as percentage of control or percentage of PMA response.
Measurement of arachidonic acid release After labelling of keratinocytes with [3H]oleic acid or [3H]-arachidonic acid, medium was aspirated and the cells were washed with solution A containing 0. I% BSA to remove unincorporated radioactivity. Cells were placed in 2 ml of basal medium containing 0.1 % BSA, at timed intervals, equilibrated for 15 min and then treated with the specified agonists. At the indicated times 0.5 ml of medium was removed, the remainder of the medium was aspirated, and the cells were scraped into icecold methanol. Cellular lipids were extracted with chloroform (Preiss et al., 1987) , and counted for radioactivity. The sample of medium removed was acidified with HCI and extracted with 1.5 ml of ethyl acetate. The ethyl acetate extracts were dried in scintillation vials, counted for radioactivity and normalized to incorporation of radioactivity into total cellular lipids.
Statistlcal methods
For measurements of MARCKS protein phosphorylation, comparisons among treatment groups were performed by the analysis ofvariance method (ANOVA) and the least-significant-difference test. Summary statistics are reported as means+ S.E.M.
RESULTS

Inositol phosphate formation In response to TGF-a and EGF
Growth-factor-deprived human adult skin fibroblasts and keratinocytes were labelled with myo-[3H]inositol (2 uCi/ml) and treated with EGF and TGF-a in the presence of LiCl for varying periods of time. The concentrations of EGF and TGF-a used were saturating with respect to EGF receptor binding (see below). No detectable increase in [3H]inositol phosphates was observed (results not shown). To increase sensitivity, fibroblasts and keratinocytes were labelled with 10 times more of myo-[3H]inositol (20 ,uCi/ml). This resulted in a 10-fold greater incorporation of label into Ptdlns. We were, however, still unable to detect any increased formation of [3H]inositol phosphates in either fibroblasts or keratinocytes in response to EGF and/or TGF-a (Figure 1) . Ptdlns hydrolysis was, however, readily detectable in response to thrombin and Lys-bradykinin in fibroblasts and keratinocytes, respectively (Figure 1 ), as previously reported (Wright et al., 1988; Talwar et al., 1989 
EGF receptor expression and activation In fibroblasts and keratinocytes
It is well established that growing adult dermal fibroblasts and keratinocytes express functional EGF receptors (Schaudies et al., 1985; Nickoloff and Mitra, 1989; Khandke et al., 1991) . One possible explanation for the observed lack of EGF/TGF-ainduced Ptdlns turnover is that EGF receptors were downregulated during the 48 h of culture in growth-factor-free basal medium, before exposure to EGF and/or TGF-a. We therefore determined EGF receptor number and affinity in fibroblasts and keratinocytes under culture conditions similar to those we had employed to measure EGF/TGF-a-induced PtdIns hydrolysis, i.e. after culture for 48 h in basal growth-factor-free medium. Figure 3 displays the concentration-dependence of EGF binding in cultured fibroblasts (a) and keratinocytes (b). In fibroblasts, Scatchard analysis yielded a linear plot, with a calculated Kd of 1.81 nM and 66800 EGF receptors per cell (Figure 3a, insert) . In keratinocytes, cultured for 48 h in basal medium, a curvilinear Scatchard plot was obtained (Figure 3b, insert) , indicating both high-(Kd = 0.738 nM, 51600 receptors per cell) and low (Kd = 5.82 nM, 175 500 receptors per cell) affinity classes of EGF receptors. These values are consistent with other measurements of EGF receptor number and affinity in fibroblasts and keratinocytes (Schaudies et al., 1985; Wiley et al., 1989; Nickoloff and Mitra, 1989; Khandke et al., 1991) and demonstrate that EGFreceptor down-regulation does not occur in either cell type cultured in basal medium for 48 h. These data therefore rule out the possibility that the lack of EGF/TGF-a-induced Ptdlns turnover is due to down-regulation of EGF receptors.
An alternative explanation for the lack of Ptdlns turnover in response to EGF/TGF-a in fibroblasts and keratinocytes is that EGF receptors may have become desensitized after culture in basal medium for 48 h. In order to examine this possibility, fibroblasts and keratinocytes, cultured in basal medium for 48 h, were treated with TGF-a (50 nM) for 2-5 min and the cell lysates were immunoblotted and probed with anti-phosphotyrosine monoclonal antibodies to measure TGF-a-stimulated tyrosine phosphorylation. Increased phosphotyrosine content of the 170 kDa EGF receptor and several other proteins was observed in response to TGF-a in both fibroblasts and keratinocytes (Figure 3c ). EGF and TGF-a induced tyrosine phosphorylation of the 170 kDa EGF receptor to a similar degree in fibroblasts and keratinocytes ( Figure 3c , and results not shown). This 170 kDa band co-migrated with the phosphorylated EGF receptor in A43 1 membranes (results not shown), and was immunoprecipitated by anti-EGF-receptor monoclonal antibodies (Klein et al., 1992) , confirming its identity as the EGF receptor. Thus, under culture conditions in which EGF/TGF-a did not induce PtdIns turnover in fibroblasts and keratinocytes, we observed substantial activation of the EGF-receptor tyrosine kinase in response to TGF-a. These data rule out the possibility that desensitization of the EGF receptor accounts for the lack of PtdIns turnover in response to EGF/TGF-a in human fibroblasts and keratinocytes. 
Expression and tyrosine phosphorylation of PLC-y1 In cultured fibroblasts and keratinocytes
Recent evidence indicates that EGF-and TGF-a-induced Ptdlns hydrolysis is catalysed by PLC-yl (Carpenter and Cohen, 1990) . PLC-yl binds to the EGF receptor through interaction of SH2 domains with phosphotyrosine residues, and itself undergoes tyrosine phosphorylation, resulting in its activation (Vega et al., 1992 of PLCy1 was readily detectable (Figure 4e ), as previously reported (Meisenhelder et al., 1989 demonstrate TGF-a-induced PLC-y1 tyrosine phosphorylation. To examine this, cells were treated with bryostatin for 18 h, which results in down-regulation of Ca2+-dependent PKC activity by more than 90% (Klein et al., 1992) , with only a transient decrease in EGF receptor expression (Sako et al., 1987; Jetten et al., 1989) (Strulovici et al., 1991; Fisher et al., 1993) . Thus attenuation of EGF-receptormediated PLC-yl phosphorylation by one or more Ca2+-independent PKC isoenzymes cannot be ruled out.
Effect of EGF and TGF-x on PC hydrolysis and PLD activity in cultured keratinocytes Having found no evidence for coupling of EGF-receptor activation to Ptdlns hydrolysis in either skin fibroblasts or keratinocytes, we next examined coupling of EGF-receptor activation to PC hydrolysis. We have previously observed EGF-stimulated PC hydrolysis in cultured human skin fibroblasts (Fisher et al., 1991) . In keratinocytes, incubation with PMA, EGF or TGF-a for between 5 and 30 min failed to raise the levels of intracellular or extracellular choline or phosphocholine (results not shown).
To serve as a positive control, keratinocytes were treated with exogenous bacterial PLC (1 unit/ml) for 10 min. As expected, this produced a 9-fold rise in the level ofphosphocholine released into the medium, whereas choline and phosphocholine levels within the cell remained unaltered (results not shown). These data suggest that, in contrast with fibroblasts, EGF and/or TGF-x do not induce PC hydrolysis in human keratinocytes.
To assess further the coupling of the EGF receptor to PLD activation, we next treated [3H]myristic acid-labelled keratinocytes with agonists, in the presence of 0.5 % ethanol, and determined [3H]phosphatidylethanol production. The transfer of an alcohol to the phosphatidyl group of a phospholipid substrate is a unique property of PLD (reviewed by Shukla and Halenda, 1991) and is a more specific and sensitive assay of PLD activity, in intact cells, compared with choline release. No stimulation of PLD activity was observed in keratinocytes after incubation with TGF-a for 15 min or 30 min (results not shown). Increased PLD activity was, however, observed in response to PMA, as reported in other cell types (Shukla and Halenda, 1991) . These data indicate that, although PLD activity is expressed in human keratinocytes, it is not stimulated by EGF or TGF-a. This is in contrast with human skin fibroblasts, in which we have previously observed PLD activation in response to EGF (Fisher et al., 1991) .
In order to examine whether the observed difference in stimulation of PC hydrolysis by EGF and TGF-a between fibroblasts and keratinocytes was due to a difference in the level of endogenous PLD or PC-PLC activities, we measured in vitro PLD and PC-PLC activities in keratinocyte and fibroblasts. Under the reaction conditions employed, we detected membraneassociated PLD activity, but not cytosolic PLD or PC-PLC activities, in fibroblasts and keratinocytes. Membrane-associated PLD activity was found in the heavy membrane pellet, and was 0.6 + 0.2 nmol/h per mg of protein in keratinocytes and 1.3 + 0.3 nmol/h per mg of protein in fibroblasts. It is unlikely that this 2-fold lower activity in keratinocytes could account for the observed absence of EGF/TGF-a-stimulated PLD activity in these cells.
EGF-and TGF-cc-induced formation of DAG In fibroblasts and keratinocytes
We next examined the kinetics of DAG formation in human fibroblasts and keratinocytes stimulated with EGF and/or TGFa. In fibroblasts, as we have previously observed (Fisher et al., 1991) , EGF stimulated a 3-fold rise in DAG mass, which was maximal at S min (Figure 5a ). For comparison, fibroblasts were treated with thrombin, which we and others have shown to induce rapid hydrolysis of Ptdlns (Wright et al., 1988) . In contrast with EGF, thrombin induced a biphasic pattern of DAG formation, with an early peak at 20 s and a second peak at 5 min ( Figure Sa) . Data from several laboratories indicate that the early rise in agonist-induced 1,2-DAG formation is mainly derived from inositol phospholipids, whereas the second, delayed, peak occurs principally from hydrolysis of PC (Wright et (Talwar et al., 1989 (Talwar et al., , 1990 (Farese et al., 1987; Kiss and Anderson, 1989 (Graff et al., 1989) . Initially, we characterized the phosphorylation of MARCKS in response to PMA and confirmed its identity as a 80 kDa protein, in fibroblasts and keratinocytes, by immunoprecipitation (Figure 6a) (Shinomura et al., 1991) , both alone and synergistically with DAG. Arachidonic acid also enhances PKC activation in intact cells (Yoshida et al., 1992 (Gill and Lazar, 1981) . Furthermore, deletional studies with the PDGF receptor suggest that Ptdlns hydrolysis is not sufficient for mitogenesis (Escobedo and Williams, 1988; Morrison et al., 1990) . Moreover, a specific point mutation in fibroblast growth factor (FGF) receptors abrogated FGF-induced PLC-yl phosphorylation and Ptdlns hydrolysis without affecting the mitogenic effect of FGF (Peters et al., 1992; Mohammadi et al., 1992) . These studies suggest that PLC-yl phosphorylation and Ptdlns hydrolysis may not be required for cell growth induced by activation of tyrosine kinase receptors. The observed differences in PC hydrolysis between skin fibroblasts and keratinocytes suggests a possible mechanism for diversity of response to EGF/TGF-a among different cell types. The lack of Ptdlns hydrolysis, PC hydrolysis or DAG formation, in response to EGF or TGF-a in keratinocytes, indicates that EGF receptor activation is not coupled to PtdIns-PLC, PC-PLC or PLD in these cells. We observed only a modest increase in MARCKS phosphorylation in response to TGF-a (50 nM) in keratinocytes. Furthermore, no significant activation of PKC was observed in response to lower doses of TGF-a (1 and 10 ng/ml) that are known to be mitogenic. Therefore, the wellcharacterized mitogenic effect of EGF and TGF-a in keratinocytes is likely to be independent of PKC activation. These data are consistent with the participation of PKC in keratinocyte terminal differentiation. Activation of PKC by PMA in keratino- Protein kinase C activation by growth factors in human skin cells cytes leads to growth arrest and induction of phenotypic differentiation, i.e. cell cornification (Hawley-Nelson et al., 1982) . There is no evidence that, in keratinocytes, down-regulation of PKC activity by bryostatin leads to potentiation of EGF receptor kinase activity or enhanced TGF-a autoinduction (Klein et al., 1992) . In human dermal fibroblasts, which do not undergo phenotypic differentiation or growth in response to PMA, PKC may serve, among other things, to act as a negative regulator of EGF-receptor activation, as demonstrated in other cell types (Wahl and Carpenter, 1988; Hepler et al., 1988; Decker et al., 1990) .
Finally, our data suggest that in skin fibroblasts DAG formed through PC hydrolysis is able to activate PKC. The observed time courses of EGF-induced DAG elevation and MARCKS phosphorylation are consistent with this conclusion. In contrast, Leach et al. (1991) failed to observe PKC activation in the presence of increased DAG formed through PC hydrolysis, and prolonged treatment of Swiss 3T3 fibroblasts with PMA did not inhibit the mitogenic effect ofexogenous Bacillus cereus PC-PLC, suggesting that the mitogenic effect of PC-PLC was independent of PKC activation (Larrodera et al., 1990 ). These differences presumably reflect differences among cell types, perhaps in expression of PKC isoenzymes. IIC9 fibroblasts express a, but not ,8 or y, PKC isoforms (Leach et al., 1991) . The expression of non-conventional PKC isoforms, however, has not been defined in these cells. Human dermal fibroblasts express the 8, c and C PKC isoforms in addition to PKC-a (Fisher et al., 1993) , and this may account for the observed differences between these cell types.
Why EGF and/or TGF-a stimulates PC hydrolysis in human dermal fibroblasts, but not in keratinocytes, remains to be elucidated. Fibroblasts and keratinocytes express similar levels of high-affinity EGF receptors and membrane-associated PLD activities. EGF and TGF-a induce EGF-receptor tyrosine phosphorylation in fibroblasts and keratinocytes to a similar degree. These data suggest that coupling of EGF receptor to PC hydrolysis is different in fibroblasts and keratinocytes.
In summary, three major conclusions emerge from our studies: (1) in two normal cell types from human skin, EGF receptor activation is not coupled to stimulation of PLC-yl or Ptdlns hydrolysis, (2) coupling of EGF-receptor activation to PC turnover is cell-type specific, and (3) DAG formed from PC hydrolysis is capable of activating PKC, in skin fibroblasts.
